News and Announcements
Shivom: release of Alpha 2.0 and upcoming networking events
- Published March 13, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- Shivom announces the launch of the Beta version of their platform with the release of Alpha 2.0 and partnership with Lifebit.
- Advancements include avatars, notifications, enterprise search functionality, an upgraded UI and a blockchain transaction and verification for DNA file-uploading.
- Shivom delegates continue to foster new relationships with like-minded individuals at a variety of conferences and roadshows throughout 2019.
Shivom announces the launch of the Beta version of their platform with the release of Alpha 2.0. The Alpha version was rolled out in November 2018, and since them a new partnership with Lifebit was established, followed months of improvements, fixing bugs and the integration of new features.
Advancements to the platform include avatars, notifications, enterprise search functionality, an upgraded UI and the elimination of bugs throughout the system. The final advancement includes a blockchain transaction and verification for DNA file-uploading enabling the platform to verify via blockchain when a file is uploaded, secured and encrypted via Shivom. The next release will include sequencing kits, an integrated wallet, marketplace and secure-sharing features.
Shivom delegates continued to foster new relationships with like-minded individuals at the Precision Medicine World Conference 2019 in California, Sixth R&D Data Intelligence Leaders Forum 2019 in Switzerland and the World Economic Forum Annual Meeting in Switzerland.
Upcoming events include:
- March 18-20: Asia’s Pharma & Biotech Festival – Phar-East 2019 in Singapore
- April 10-11: Big-Data.AI Summit 2019 in Berlin
- April 16-18: Bio-IT World Conference & Expo 2019 in Boston
- April 24-25: Digital Health 2019 in Houston, US
- Conferences and roadshows throughout China, Russia, Japan, South Korea, Singapore, Australia, UK, Germany, Switzerland, Greece, Italy, Finland, Latvia, Australia, India, UAE, Canada and USA.
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
